Activity content starts in:
Industry Webcast
Rethinking Hypertension Management: A Novel, Aldosterone-Targeted Approach for Uncontrolled Blood PressureIndustry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit
This evidence-based review examines the persistent unmet need in adults whose blood pressure remains uncontrolled despite treatment, leaving them at elevated cardiovascular risk. Explore the latest hypertension clinical practice guidelines, aldosterone’s critical role in driving hypertension, and the clinical rationale for treatment. Explore how a novel approach may support blood pressure control and cardiovascular risk reduction.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 9/16/2026
Expiration Date: 9/16/2026
Topics
Faculty
Faculty
Supporters and Partners
Industry Sponsor
AstraZeneca
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.